Select Medical (NYSE:SEM) Upgraded at StockNews.com

Select Medical (NYSE:SEM) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research report issued on Tuesday.

A number of other brokerages have also weighed in on SEM. UBS Group lowered their price objective on Select Medical from $40.00 to $21.00 and set a “neutral” rating on the stock in a report on Friday, January 3rd. Royal Bank of Canada lifted their price target on Select Medical from $40.00 to $47.00 and gave the company an “outperform” rating in a research note on Monday, November 4th. Finally, Benchmark cut Select Medical from a “buy” rating to a “hold” rating in a research report on Monday, November 25th. Two analysts have rated the stock with a hold rating and three have given a buy rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average price target of $39.50.

Select Medical Trading Up 0.6 %

NYSE:SEM opened at $18.75 on Tuesday. Select Medical has a 12-month low of $18.02 and a 12-month high of $40.98. The company has a current ratio of 1.13, a quick ratio of 1.13 and a debt-to-equity ratio of 1.37. The stock’s 50 day simple moving average is $26.34 and its 200-day simple moving average is $31.97. The firm has a market cap of $2.43 billion, a P/E ratio of 8.76, a PEG ratio of 0.39 and a beta of 1.45.

Select Medical (NYSE:SEM) last announced its quarterly earnings data on Thursday, October 31st. The health services provider reported $0.43 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.36 by $0.07. Select Medical had a net margin of 3.97% and a return on equity of 15.99%. The company had revenue of $1.76 billion for the quarter, compared to analysts’ expectations of $1.74 billion. During the same period in the previous year, the company posted $0.46 EPS. Select Medical’s revenue was up 5.7% compared to the same quarter last year. Equities analysts anticipate that Select Medical will post 1.97 EPS for the current year.

Insiders Place Their Bets

In related news, Director Marilyn B. Tavenner sold 32,000 shares of the company’s stock in a transaction that occurred on Tuesday, November 26th. The stock was sold at an average price of $21.09, for a total value of $674,880.00. Following the sale, the director now owns 22,000 shares of the company’s stock, valued at approximately $463,980. This represents a 59.26 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, VP Robert G. Breighner, Jr. sold 4,989 shares of the firm’s stock in a transaction on Wednesday, December 4th. The stock was sold at an average price of $19.95, for a total value of $99,530.55. Following the transaction, the vice president now directly owns 30,356 shares of the company’s stock, valued at $605,602.20. The trade was a 14.12 % decrease in their position. The disclosure for this sale can be found here. 19.14% of the stock is owned by company insiders.

Institutional Trading of Select Medical

Large investors have recently made changes to their positions in the stock. Point72 Asset Management L.P. lifted its holdings in Select Medical by 144.2% in the 3rd quarter. Point72 Asset Management L.P. now owns 2,059,791 shares of the health services provider’s stock valued at $71,825,000 after purchasing an additional 1,216,263 shares in the last quarter. Millennium Management LLC boosted its position in Select Medical by 183.9% during the second quarter. Millennium Management LLC now owns 679,522 shares of the health services provider’s stock worth $23,824,000 after acquiring an additional 440,140 shares during the last quarter. Hood River Capital Management LLC purchased a new stake in Select Medical in the 2nd quarter worth approximately $14,819,000. Loomis Sayles & Co. L P acquired a new position in Select Medical in the 3rd quarter valued at $9,710,000. Finally, LMR Partners LLP acquired a new stake in shares of Select Medical during the third quarter worth $6,139,000. Institutional investors and hedge funds own 89.48% of the company’s stock.

Select Medical Company Profile

Select Medical Holdings Corporation, through its subsidiaries, operates critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States. It operates in four segments: Critical Illness Recovery Hospital, Rehabilitation Hospital, Outpatient Rehabilitation, and Concentra.